Abstract:Background: Oxidative stress, neuroinflammation, neuronal loss, and demyelination contribute to mechanisms of s pinal cord injury (SCI). Reactive oxygen species (ROS) have been reported to be associated with SCI , which can trigger the pathways toward cellular pyroptosis. Accumulating evidence has suggested that oxidative stress caused by mitochondrial dysfunction play a vital role in the pathophysiology of SCI. In the present study, we explore the effects and mechanisms of SS-31, a mitochondria-targeted antioxidant , on SCI in vivo and vitro. Methods: Functional recovery was assessed using Basso Mouse Scale (BMS) and BMS subscore. Oxidative stress was evaluated using detection of malonaldehyde (MDA) and 3-nitrotyrosine(3-NT). Neuronal loss was evaluated by immunochemistry staining of NeuN. Pyroptosis was assessed by flow cytometry and western blot. Findings: Administration of SS-31 to mice significantly improved locomotor functional recovery up to 28 days after SCI and suppressed neuronal loss and demyelination in mice. Moreover, SS-31 attenuated oxidative stress, inhibited nucleotide-binding oligomerization domain-like receptor 3 (NLRP3) inflammasome activation and pyroptosis occurrence, and decreased proinflammatory cytokines levels in mice. Furthermore, SS-31 in oxygen-glucose deprivation neurons promoted the survival , alleviated mitochondrial dysfunction, decreased oxidative stress, and suppressed NLRP3 inflammasome activation and pyroptosis . Interpretations: Together, our findings reveal that mitochondria-targeted antioxidant SS-31 can improves locomotor functional recovery in mice after SCI and that SS-31-mediated neuroprotection presumably depends on the attenuation of pyroptosis, mitochondrial dysfunction, neuroinflammation and oxidative stress. Funding Statement: This study was supported by National Natural Science Foundation of China (grant.81702163), Zhejiang Provincial Public Welfare Research Project (grant.LGF20H060014), Zhejiang Provincial Medical and Health Technology Project (grant.2020KY699), Science and Technology Development Project of Hangzhou (grant.20170533838), Zhejiang Provincial Public Welfare Research Project (grant.LGF21H060004). Declaration of Interests: The authors declare no competing financial interest. Ethics Approval Statement: All animal studies (including the mice euthanasia procedure) were done in compliance with the regulations and guidelines of Hangzhou First People's Hospital's institutional animal care and conducted according to the Association for Assessment and Accreditation of Laboratory Animal Care international (AAALAC) and the Institutional Animal Care and Use Committee (IACUC) guidelines.

Necrosulfonamide Ameliorates Neurological Impairment in Spinal Cord Injury by Improving Antioxidative Capacity

Necrosulfonamide Alleviates Acute Brain Injury of Intracerebral Hemorrhage via Inhibiting Inflammation and Necroptosis

MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice

Natrium Benzoate Alleviates Neuronal Apoptosis Via the DJ-1-Related Anti-oxidative Stress Pathway Involving Akt Phosphorylation in a Rat Model of Traumatic Spinal Cord Injury

New strategy to treat spinal cord injury: Nafamostat mesilate suppressed NLRP3-mediated pyroptosis during acute phase

Improving Functional Recovery after Severe Spinal Cord Injury by a Noninvasive Dual Functional Approach of Neuroprotection and Neuromodulation

Abstract 179: Effects of Necrosulfonamide on Post-Resuscitation Survival and Neurological Function in a Rat Model of Cardiac Arrest

Necrosulfonamide Improves Post-Resuscitation Myocardial Dysfunction Via Inhibiting Pyroptosis and Necroptosis in a Rat Model of Cardiac Arrest.

Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCI

Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson’s disease

Nafamostat Mesilate Attenuates Inflammation and Apoptosis and Promotes Locomotor Recovery after Spinal Cord Injury.

Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis

Synergistic neuroprotective effects of hyperbaric oxygen and N-acetylcysteine against traumatic spinal cord injury in rat

Mitochondria-Targeted Antioxidant SS-31 Attenuates Mitochondrial Dysfunction, Reduces Pyroptosis and Improves Locomotor Functional Recovery After Spinal Cord Injury

Correction to “Polysialic-Acid-based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy”

Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice

Neuroprotective Effects of Oxymatrine via Triggering Autophagy and Inhibiting Apoptosis Following Spinal Cord Injury in Rats

Necrostatin-1 Mitigates Mitochondrial Dysfunction Post-Spinal Cord Injury

The Degradation of Mixed Lineage Kinase Domain-Like Protein Promotes Neuroprotection after Ischemic Brain Injury

Coenzyme Q10 Suppresses Oxidative Stress and Apoptosis Via Activating the Nrf-2/NQO-1 and NF-κB Signaling Pathway after Spinal Cord Injury in Rats.

Macrophage membrane-modified reactive oxygen species-responsive prodrug self-assembled nanoparticles for the targeted treatment of traumatic spinal cord injury